Cellectis (CLLS) Intangibles (2013 - 2026)

Cellectis (CLLS) posted quarterly Intangibles of $221000.0 for Q1 2026, down 8.68% year-over-year from $242000.0 in Q1 2025, and down 58.69% quarter-over-quarter from $535000.0 in Q4 2025.

Cellectis (CLLS) Intangibles (2013 - 2026) Analysis & Trends

Cellectis' Intangibles history runs 14 years deep, the most recent figure standing at $221000.0 for Q1 2026.

  • In Q1 2026, Intangibles fell 8.68% year-over-year to $221000.0; the TTM figure through Mar 2026 stood at $221000.0 (down 8.68% YoY), while the FY2025 annual figure was $535000.0, down 52.06% from the prior year.
  • Intangibles for Q1 2026 stood at $221000.0, down from $535000.0 in the prior quarter.
  • The five-year high for Intangibles was $1.7 million in Q1 2022, with the low at $221000.0 in Q1 2026.
  • The 5-year median for Intangibles is $695000.0 (2023), against an average of $846176.5.
  • Peak annual rise in Intangibles reached 76.57% in 2025, while the deepest fall reached 64.25% in 2025.
  • Cellectis' Intangibles stood at $718000.0 in 2022, then fell by 6.55% to $671000.0 in 2023, then surged by 66.32% to $1.1 million in 2024, then tumbled by 52.06% to $535000.0 in 2025, then sank by 58.69% to $221000.0 in 2026.
  • Business Quant data shows CLLS's Intangibles at $221000.0 in Q1 2026, $535000.0 in Q4 2025, and $845000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 412.80 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.31 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 266.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 63.28 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 60.96 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 93.49 Mn
10 Cellectis 306.61 Mn 120.95 Mn - 221,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 221,000.00
Dec 31, 2025 535,000.00
Sep 30, 2025 845,000.00
Jun 30, 2025 1.15 Mn
Mar 31, 2025 242,000.00
Dec 31, 2024 1.12 Mn
Sep 30, 2024 691,000.00
Jun 30, 2024 653,000.00
Mar 31, 2024 677,000.00
Dec 31, 2023 671,000.00
Sep 30, 2023 662,000.00
Jun 30, 2023 695,000.00
Mar 31, 2023 713,000.00
Dec 31, 2022 718,000.00
Sep 30, 2022 1.51 Mn
Jun 30, 2022 1.58 Mn
Mar 31, 2022 1.70 Mn
Dec 31, 2021 1.85 Mn
Sep 30, 2021 2.55 Mn
Jun 30, 2021 1.58 Mn